Ambarella Inc: Form 10-Q for the period ended Apr 30, 2024
Filed with the SEC on Jun 6, 2024 and accepted by EDGAR at Jun 6, 2024, 14:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-02-01 to 2024-04-30 | $54.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-02-01 to 2024-04-30 | $21.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-02-01 to 2024-04-30 | $33.2m | us-gaap:GrossProfit |
| Research and development | 3 months2024-02-01 to 2024-04-30 | $54.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-02-01 to 2024-04-30 | $18.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-02-01 to 2024-04-30 | −$39.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-02-01 to 2024-04-30 | $758.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-02-01 to 2024-04-30 | −$37.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-02-01 to 2024-04-30 | −$0.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-02-01 to 2024-04-30 | −$0.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-02-01 to 2024-04-30 | 40,774,991 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-02-01 to 2024-04-30 | −$15.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-02-01 to 2024-04-30 | $1.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2024-04-30 | $131.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-04-30 | $266.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-04-30 | $638.7m | us-gaap:Assets |
| Current liabilities | At period end2024-04-30 | $72.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-04-30 | $83.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-04-30 | $555.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-069790. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.